EAACI Congress 2025
BackL-TPS16 - Asthma 11
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
100480
The Association Between Selective IgA Deficiency and Bronchial Asthma in Children Aged 4–18 Years: A Systematic Review
D3.157
A study of the detailed patterns of wheeze presence and absence from infancy through to adolescence
D3.158
Clinical and functional profile of children with asthma in a tertiary referral hospital
D3.153
ETB receptor signaling regulates allergic airway inflammation and hyperreactivity
D3.150
Effects of benralizumab on T cell adhesion molecules in severe eosinophilic asthma: modulation by IL-25 and IL-33
D3.155
IL-1 signaling pathway molecules as key markers in childhood severe asthma
D3.159
Investigation of Huai Qi Huang Granules' Impact and Mechanism on Asthmatic Mice's Antiviral Capability
D3.163
Mast cell activation test and airway hyperresponsiveness in cat allergy: investigating the link to cat allergen induced asthma
D3.148
Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab
D3.152
Phenotype and treatment response of allergic patients with severe asthma: a real-world experience from Argentina
D3.151
Prevalence and clinical characteristics of adult asthma patients with different phenotype across GINA step 1 to 5 asthma
D3.154
Safety of allergen immunotherapy in patients with severe asthma. A real-world, multicentre, observational retrospective study
D3.156
Self-reported asthma symptoms and asthma medication usage in patients with possible asthma: A MASK-air® real-world study
D3.162
The Effects of Phthalate Exposure on Asthma via Microbiota Changes
D3.147
The inhaled PDE4 inhibitor tanimilast shows a broad anti-inflammatory effect in two mouse models of asthma induced by house dust mite
D3.149
Worse airflow obstruction but not type 2 biomarkers identifies super-responders to tezepelumab in a real life clinic setting
